3-Month Protocol: $445 $148/mo save $80 6-Month Protocol: $840 $140/mo save $210 The $175/month fee includes the pharmaceutical-grade compound from a licensed compounding pharmacy, medical oversight, and ongoing access to your provider for protocol adjustments
In some embodiments, the otic pharmaceutical formulation comprises about 50%, about 51%, about 52%, about 53%, about 54%, about 55%, about 56%, about 57%, about 58%, about 59%, about 60%, about 61%, about 62%, about 63%, about 64%, about 65%, about 66%, about 67%, about 68%, about 69%, about 70%, about 71%, about 72%, about 73%, about 74%, about 75%, about 76%, about 77%, about 78%, about 79%, about 80%, about 81%, about 82%, about 83%, about 84%, about 85%, about 86%, about 87%, about 88%, about 89%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98% , or about 99% by weight of the triglycerides
When combined with semaglutide in CagriSema, results are comparable to Zepbound, though slightly lower in a head-to-head trial
Limited Long-Term Research There is still limited long-term data on the safety of AOD-9604, especially with extended use
